New Key Statistics Module, Z-Score and F-Score
NAS:TGTX Key Ratios
Market Cap $ M | 3,421.58 |
Enterprise Value $ M | 3,196.74 |
P/E(ttm) | 100.64 |
PE Ratio without NRI | 100.64 |
Forward PE Ratio | 92.12 |
Price/Book | 21.29 |
Price/Sales | 11.69 |
Price/Free Cash Flow | 223.62 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 289.00 |
EPS (TTM) $ | 0.22 |
Beneish M-Score | 26.44 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 59.56 |
EV-to-EBITDA | 59.13 |
PEG | -- |
Shares Outstanding M | 154.54 |
Net Margin (%) | 14.24 |
Operating Margin % | 16.71 |
Pre-tax Margin (%) | 14.38 |
Quick Ratio | 2.84 |
Current Ratio | 3.62 |
ROA % (ttm) | 14.18 |
ROE % (ttm) | 37.23 |
ROIC % (ttm) | 94.75 |
Dividend Yield % | -- |
Altman Z-Score | 5.62 |
TGTX Number of Guru Trades
TGTX Volume of Guru Trades
Gurus Latest Trades with NAS:TGTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TGTX is held by these investors
Total 2
TG Therapeutics Inc Insider Transactions
No Available Data
News about NAS:TGTX
Total 0- 1